Summary. Viable human pancreatic islets isolated from a recent-onset Type 1 (insulin-dependent) diabetic patient were used to perform in vitro studies. Pre-proinsulin mRNA and insulin content, as well as insulin response were analyse d . Insulin response to glucose and forskolin was completely absent in diabetic islets, as compared to control islets. Insulin content was reduced to only one-third of control values (395.0 + 3.5 vs 989.0 _+ 46.3 gU/islet) and 20.7 + 3.9 % of islets from the diabetic pancreas contained insulin-positive cells in immunofluorescence studies. Northern blot analysis revealed a severe reduction in the content of pre-proinsulin mRNA in diabetic pancreatic tissue. Our results indicate that although markedly decreased, beta cells in human pancreatic islets at the onset of Type 1 diabetes are still present. Nevertheless, pancreatic islet function is disproportionately impaired with a complete absence of an insulin response.
sulin-dependent) diabetes mellitus.
Type i (insulin-dependent) diabetes mellitus is an autoimmune disease caused by the selective destruction of islet beta cells. Attempts have been made to define the immunopathological aspects of this destruction. This has shown that pancreatic tissue from newly-diagnosed Type i diabetic patients presents several distinct features including: severely reduced beta-cell mass, various degrees of expression of MHC class I and class II antigens in islet cells and lymphocytic infiltrates [1] [2] [3] . However, the beta-cell secretory function of this clinical entity has only been evaluated in in vivo studies [4] .
We report here the first study in which viable human pancreatic islets were isolated from a recent-onset Type 1 diabetic patient and thus were used to perform in vitro functional studies.
Subjects and methods
After obtaining the family's informed consent and with the approval of the Hospital Ethics Committee, human pancreatic islets were isolated from the pancreas of a islet cell antibody positive 18-year-old woman who had died 6 h after her admission because of diabetic ketoacidosis. She had been asymptomatic up to 2 days prior to admission when polydipsia, polyuria and polyphagia were observed. Islets were obtained following a modification of Ricordi's automatic digestion technique [5] . The pancreas from the diabetic patient was treated in the same manner as the pancreata obtained from the control cadaveric organ donors with a similar time period between death and pancreas removal. Briefly, after the pancreatic duct was cannulated, Hanks' balanced salt solution (HBSS) at 37 ~ containing 1% newborn calf serum (NCS; Gibco, Paisley, UK), 2.5 mg/ml collagenase (Type P; Boehringer Mannheim, Mannheim, FRG) and 0.04mg/ml deoxyribonuclease (DNAseI; Sigma, St.Louis, Mo., USA) was injected. The pancreas was loaded into a digestion chamber and was connected to a closed circuit with recircularization of the medium and continuously shaken. Samples were taken every 3 min, stained with dithizone (DTZ; Sigma) and then examined under stereomicroscope. When free islets were detected the digestion was stopped by quickly cooling the digestion chamber. Dispersed pancreatic tissue was washed several times in HBSS by centrifugation at 60 x g at 4~ Cell viability was assessed by ethidium bromide/ acridine orange (Sigma) staining.
Cryostat sections of 5 gm were dried for 30 min and stained by an indirect immunofluorescence method using an anti-C-peptide (Pep030, kindly provided by Novo-Nordisk, Copenhagen, Denmark), anti-glucagon (Glu001, Novo-Nordisk) and anti-somatostatin (Som018, Novo-Nordisk) antibodies.
Batches of six hand-picked islets of similar size from the digested pancreatic tissue were incubated in a shaking water bath for 90 rain at 37~ in 1.0 ml bicarbonate-buffered medium containing bovine serum albumin (5.0 mg/ml; Fraction V, Sigma) and m-glucose at 5.5, 11.1, 16.7 mmol/1; D-glucose (16.7mmol/1) plus forskolin (0.005 mmol/1, Sigma). For the first 10 min of incubation, the vials containing the incubation medium with the islets were gassed with O2:COa (95 % :5 %). At the end of the incubation period supernatants were aliquoted and stored at -20~ until assayed for insulin by an RIA method (CIS, Biointernational, Gif-Sur-Yvette, France). The method allows the determination of 2.5 gU/ml, with a coefficient of variation within and between assays of 6 % and 8 % respectively. Insulin release is expressed in btU insulin, islet-1.90-min -1 Groups of ten islets were disintegrated by ultrasonic disruption (Branson Sonifier 250, London, UK) at 4~ in 0.5 ml acid-alcohol solution [75 % (v/v) ethanol, 23.5 % bi-distilled water and 1.5 % (v/v) 10 N HCL]. The homogenates were kept at -20~ until insulin was assayed by RIA. Insulin content was expressed in gU of insulin per islet.
Total RNA was isolated by the method of Chirgwin [6] . Briefly, frozen tissue ( -70~ from the head of the pancreas was disrupted in guanidinium isothiocyanate solution, layered onto a cushion of cesium chloride, and spun in an SW55 Ti rotor (Beckman, Palo Alto, Calif., USA) at 152,000 x g overnight. The RNA pellet was resuspended, phenobchloroform extracted, and concentrated by ethanol precipitation. RNA concentration in each sample was determined by optical density at 260 nm. RNA preparations were denatured, electrophoresed through formaldehyde/agarose gels, and transferred to Z probe nylon membranes (Bio-Rad Laboratories, Richmond, Calif., USA). The integrity of the RNA was confirmed in all cases by inspection of the ethidium bromide stained gel. The membranes were hybridized with pre-proinsulin (PHINS 96) and cyclofilin cDNA probes prepared by the random priming method using
[32p]-dCTP. Pre-proinsulin mRNA-cyclofilin mRNA ratios were used to verify the accuracy of the pre-proinsulin mRNA signal.
Results were compared with islets obtained from the pancreas of non-diabetic organ donors, using the same methodology.
Results
Viability assessed by acridine orange/ethidium bromide staining was 95 % in diabetic islets and greater than 85 % in control islets.
After the digestion the yield obtained was 6400 and 5831+1081 E I N (equivalent islet number of standard 150 pm-diameter) per gramme of tissue processed from the diabetic and control pancreata (n = 29), respectively.
Insulin response to increasing glucose concentrations as well as glucose and forskolin combined in the media was completely absent in diabetic islets, as opposed to control islets (Table 1) . Insulin content was reduced, but not absent, in diabetic islets, 395.0 ___ 3.5 pU/islet (n = 3), when compared to normal islets 989.0 +46.3 btU/islet (four pancreata, n = 3--4 replicates per pancreas).
Immunofluorescence staining of sections from the diabetic pancreas revealed that all 371 islets examined contained glucagon-positive and somatostatin-positive cells. Only 20.7 + 3.9 % of these islets contained insulinpositive cells.
Northern blot analysis disclosed a severe reduction in the content of pre-proinsulin m R N A in diabetic pancreatic tissue (Fig. 1) .
Discussion
This study describes data concerning pre-proinsulin m R N A and insulin content, as well as in vitro insulin secretion behaviour of human endocrine pancreatic tissue at the onset of Type i diabetes. In addition, results obtained from immunological and molecular studies on this tissue have been previously reported [7] .
The results obtained from immunofluorescence studies demonstrated the presence of glucagon-positive and somatostatin-positive cells not only in insulin-positive islets but also in non-insulin-containing cell specimens from the diabetic pancreas. This observation rules out the suspicion that the absence of insulin-containing beta-cells in about 80 % of these specimens means that they may not represent true endocrine tissue. In order to further guarantee that what we isolated from the diabetic pancreas were islets, the authors refer to previous experience in which handpicked islets (control islets) were later stained with dithizone and more than 95 % were found to be dithizone positive. Thus the authors feel confident that true islets were employed.
In our study, we observed the absence of an insulin secretory response to both a nutrient and a non-nutrient secretagogue. This could not be explained only by the destruction of beta-cell mass since the reduction of the insulin content of these islets was one-third that of control values. Pre-proinsulin m R N A levels were also clearly diminished. Even so, it is unlikely that the secretory defect was due solely to abnormal transcription and synthesis of the hormone because insulin stores were not depleted. It is worth noting that while just 20 % of the islets from the diabetic pancreas contained insulin-positive cells, insulin content of the islets was 30 % of that observed in controls. This observation implies that two insulin-positive islets from ten randomly selected islets examined for insulin content must contain a normal, or higher than normal, insulin content. However, in the present study we consider that information obtained from measuring insulin content is more accurate than that provided by indirect immunofluorescence staining. Fig.1 . Northern-blot analysis of pre-proinsulin mRNA (refered to as insulin in the figure) in tissue of recent onset Type I diabetic pancreas (DM) and normal pancreas (N). Total RNA isolated from diabetic pancreas (16 bLg) and from each normal pancreas (8 gg) were hybridized with pre-proinsulin cDNA and cycIofilin cDNA Altogether, our findings are in agreement with the prevailing view derived from in vivo studies in which the initial phases of Type 1 diabetes are characterized by functional secretory defects in addition to the destruction of insulinproducing islet cells [1, 4] . Although specific defects in glucose-induced insulin response occur during the early preclinical stages of the disease, it has been shown that a generalized secretagogue insensitivity becomes apparent as the disease progresses [8] . Since Type i diabetes is an autoimmune disease, it is not surprising that several factors such as cytokines have been suggested to be involvedin the initial secretory alterations [9] . Moreover, a preferential destruction of a high glucose-sensitive beta-cell subpopulation with preservation of less glucose-sensitive cells, could be occurring at early stages of the disease [10] .
In summary, although clearly diminished, it is possible to find insulin producing cells in human pancreatic islets at the onset of Type i diabetes. Nevertheless, islet function is disproportionately impaired with a complete absence of an insulin response.
